|
MOBKL2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.535400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.862400E-01 |
| Normal-vs-Stage2 |
6.494000E-01 |
| Normal-vs-Stage3 |
7.042600E-01 |
| Normal-vs-Stage4 |
1.681000E-01 |
| Stage1-vs-Stage2 |
9.523800E-01 |
| Stage1-vs-Stage3 |
4.360000E-01 |
| Stage1-vs-Stage4 |
4.867800E-01 |
| Stage2-vs-Stage3 |
5.212200E-01 |
| Stage2-vs-Stage4 |
3.960400E-01 |
| Stage3-vs-Stage4 |
1.712760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.895600E-01 |
| Normal-vs-AfricanAmerican |
5.096600E-01 |
| Normal-vs-Asian |
1.205040E-01 |
| Caucasian-vs-AfricanAmerican |
9.327400E-01 |
| Caucasian-vs-Asian |
5.461200E-01 |
| AfricanAmerican-vs-Asian |
4.565000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.063960E-01 |
| Normal-vs-Female |
4.279800E-01 |
| Male-vs-Female |
3.549700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.283600E-01 |
| Normal-vs-Extreme_Weight |
6.148100E-02 |
| Normal-vs-Obese |
6.574000E-01 |
| Normal-vs-Extreme_Obese |
1.861850E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.863600E-01 |
| Normal_Weight-vs-Obese |
5.938600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.192200E-01 |
| Extreme_Weight-vs-Obese |
1.375410E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.714400E-01 |
| Obese-vs-Extreme_Obese |
5.786500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.118140E-02 |
| Normal-vs-Age(41-60Yrs) |
7.476400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.388550E-01 |
| Normal-vs-Age(81-100Yrs) |
4.229400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.335950E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.377400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.282200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.795700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.315800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.253200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.131800E-02 |
| Normal-VS-Type2 PRCC |
3.068600E-01 |
| Normal-VS-KIRP CIMP |
1.576440E-04 |
| Normal-VS-Unclassified PRCC |
8.553200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.796000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.902850E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.604400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.437770E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.135600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.241100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.000200E-01 |
| Normal-vs-N1 |
1.374980E-01 |
| Normal-vs-N2 |
2.051000E-01 |
| N0-vs-N1 |
4.909000E-01 |
| N0-vs-N2 |
2.148600E-01 |
| N1-vs-N2 |
8.641000E-01 |
|
|
